Brief: IRLAB Granted Patent For Drug Candidate Pirepemat

IRLAB Therapeutics AB

12/12/2023 06:09

Dec 12 (Reuters) - IRLAB Therapeutics AB  IRLABa.ST :
    * GRANTED ADDITIONAL PATENT FOR DRUG CANDIDATE PIREPEMAT
THAT
EXPANDS ITS PATENT PROTECTION
    * EXCLUSIVITY CAN POTENTIALLY REACH INTO EARLY 2040S

Source text for Eikon:  ID:nMFN7JbjCp 
Further company coverage:  IRLABa.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))